Author:
M. Abdoon Fadam,M. Atawy Hayfaa
Reference33 articles.
1. BNF 72: September 2016;Joint Formulary Committee,2016
2. Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension;Díez;Clin. Ther.,2006
3. S.C. Sweetman, Martindale: The Complete Drug Reference, 36th edition; London (Chicago), Pharmaceutical Press, 2009.
4. R.C. Williams, M.S. Alasandro, V.L. Fasone, R.J. Boucher, J.F. Edward, Comparison of liquid chromatography, capillary electrophoresis and super-critical fluid chromatography in the determination of Losartan Potassium drug substance in Cozaar® tablets. J. Pharm. Biomed. Anal. 14 (11) (1996) 1539.
5. Estimation of losartan potassium in pharmaceutical formulations: Application to content uniformity testing;Ahmed;World J. Pharm. Res.,2019